Rotate your device to portrait mode.
- Clinical
Agreement between Programmed Cell Death Ligand-1 Diagnostic Assays across Multiple Protein Expression Cutoffs in Non–Small Cell Lung Cancer
AACR Publications2017 - Clinical
Concordance of tumor and immune cell staining with Ventana SP142, Ventana SP263, Dako 28-8 and Dako 22C3 PD-L1 tests in NSCLC patient samples
Journal of Clinical Oncology2017 - Research
Megakaryocytes, erythropoietic and granulopoietic cells express CAL2 antibody in myeloproliferative neoplasms carrying CALR gene mutations
International Journal of Experimental Pathology2020 - Clinical
Concordance among four commercially available, validated programmed cell death ligand-1 assays in urothelial carcinoma
Diagnostic Pathology2019
